Industry: Pharmaceuticals, Biotechnology
CyGenics is a biotechnology and immunotherapy company focused on the development and commercialisation of adult stem cell-related products, services, applications and technologies. From its headquarters in Australia, CyGenics operates three divisions: Singapore-based CordLife (tissue banking services, in particular, cord blood banking) and Cell Sciences (consumable cell culture products), and Cytomatrix (cell therapeutics and technology development) based in the USA. CyGenics is listed on the Australian Stock Exchange, under the symbol CYN. ( www.cygenics.com )
CyGenics Ltd
212 West Cummings Park
Woburn, Massachusetts 01801
USA
Tel: (781) 939-0995
Fax: (781) 939-5707